Jeffrey Way
3 Papers
19 Citations
Jeffrey Way is an academic researcher. The author has contributed to research in topics: Internal medicine & Randomized controlled trial. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
147. A Prospective, Multi-Center, Randomized, Controlled, Blinded Trial of Vagus Verve Stimulation for Difficult to Treat Depression: The Recover Trial Baseline Data
Charles R. Conway,Scott Aaronson,Harold A. Sackeim,Christopher Kriedt,Mark Bunker,Bryan Olin,Lisa Lee,Jeffrey Way,Britt M. Gott,A. John Rush +9 more
TL;DR: In 2019, the US Centers for Medicare and Medicaid Services (CMS) requested a "coverage with evidence trial" to study Vagus Nerve Stimulation (VNS) efficacy in Medicare TRD patients as mentioned in this paper .
ASCEND: A randomized controlled trial of titration strategies for vagus nerve stimulation in drug-resistant epilepsy
Ryan Verner,Pegah Afra,Selim R. Benbadis,Anto Bagic,George Nune,Toufic Fakhoury,Daniel Winkel,Batool F. Kirmani,Roger O. Oghlakian,Travis Losey,David M. Treiman,Michael Macken,Deepak Madhavan,Kalarickal J. Oommen,Daniela Minecan,Jeffrey Way +15 more
TL;DR: In this paper , the authors describe a randomized controlled trial assessing the impact of titrating VNS according to three different protocols to achieve the target dose of 1.5 mA at 500µsec, for a 20-Hz signal frequency.